How do you tell generalized anxiety disorder from panic disorder on a vignette?

Generalized anxiety disorder is distinguished by chronic, diffuse worry with physical tension symptoms, while panic disorder features recurrent episodic panic attacks and fear of future attacks. In GAD, the anxiety is present more days than not for at least 6 months, spans multiple life domains, and is hard to control. Patients are often persistently keyed up rather than having discrete attacks.

What are the diagnostic criteria for generalized anxiety disorder that matter for Step 1?

The key criteria are excessive, hard-to-control worry about multiple areas of life occurring more days than not for at least 6 months, plus at least 3 associated symptoms. These symptoms include restlessness, fatigue, difficulty concentrating, irritability, muscle tension, and sleep disturbance. The symptoms must cause distress or impairment and not be due to a substance, medical condition, or another psychiatric disorder.

What medical conditions can mimic generalized anxiety disorder on Step 1?

Several medical and substance-related problems can mimic generalized anxiety disorder, so GAD remains a clinical diagnosis after rule-outs. High-yield mimics include hyperthyroidism, pheochromocytoma, arrhythmia, asthma or COPD, substance-induced anxiety from caffeine, stimulants, cocaine, or withdrawal, and medication-induced symptoms from albuterol, excess levothyroxine, or steroids. Exam stems often give clues like low TSH, episodic symptoms, syncope, wheeze, or a medication history.

What is the first-line treatment for generalized anxiety disorder?

First-line treatment for generalized anxiety disorder is CBT along with SSRIs or SNRIs for long-term control. CBT commonly focuses on cognitive restructuring and worry exposure or management. SSRIs such as sertraline and escitalopram, and SNRIs such as venlafaxine and duloxetine, are emphasized because serotonin and norepinephrine dysregulation are part of the disorder’s biology, although these medications take weeks to work.

Why do benzodiazepines work quickly in generalized anxiety disorder?

Benzodiazepines work quickly because they enhance GABA-A signaling, which increases inhibitory tone. Anxiety is linked in part to relatively decreased GABA-mediated inhibition, along with increased amygdala reactivity and altered prefrontal regulation, so boosting GABA can rapidly reduce symptoms. On exams, they are framed as short-term or acute relief options rather than ideal long-term therapy because of dependence concerns.

Everything You Need to Know About Generalized anxiety disorder for Step 1

Generalized anxiety disorder (GAD) is one of those Step 1 topics that seems “soft” until it shows up as a classic vignette: months of excessive, hard-to-control worry + physical tension symptoms, with normal labs and no single trigger. The trick is to recognize the pattern, separate it from panic disorder and medical mimics, and know the core treatments and mechanisms.

Where GAD Fits in the USMLE Psychiatry Map

On exams, GAD lives in the anxiety disorders bucket (alongside panic disorder, phobias, social anxiety). It’s not “fear of one thing”—it’s diffuse, persistent worry across multiple life domains.

First Aid cross-reference (Psychiatry):

First Aid for the USMLE Step 1 → Psychiatry → Anxiety disorders (GAD vs panic vs phobias), defense mechanisms, and drug adverse effects (SSRIs/SNRIs, benzos, buspirone).

Definition (The Step 1 Version)

Generalized anxiety disorder = excessive anxiety and worry occurring more days than not for at least 6 months, about a number of events or activities, that is difficult to control and causes impairment.

Diagnostic Core (High Yield)

Duration: $\ge 6$ months
Content: multiple domains (work, health, family, finances)
Control: hard to control
Associated symptoms: at least 3 (more on this below)

Pathophysiology: What’s Going On Under the Hood?

Step 1 won’t usually demand a full circuit diagram, but it will expect you to connect GAD to neurotransmitters, limbic activity, and stress biology.

Key Neurobiology Themes

Increased amygdala reactivity and altered regulation by prefrontal cortex → overestimation of threat, persistent worry.
GABA: relative decreased inhibitory tone is a common testable concept for anxiety (why benzodiazepines, which enhance GABA-A, work quickly).
Serotonin (5-HT) and norepinephrine (NE) dysregulation → rationale for SSRIs/SNRIs as first-line maintenance.
HPA axis overactivity (stress response) is often discussed in anxiety broadly; chronic stress can reinforce autonomic symptoms and hypervigilance.

Genetics and Risk

Moderate heritability; often comorbid with mood disorders.
Risk increases with chronic stress, certain personality traits (high neuroticism), and adverse life events.

Clinical Presentation: How It Shows Up on Vignettes

Think “worrier + tension + insomnia.” Patients usually aren’t having discrete “attacks”—they’re persistently keyed up.

Core Symptoms (Remember “WATCHERS”)

For GAD, associated symptoms include at least 3 of the following (for $\ge 6$ months):

Worry (excessive, hard to control)
Anxiety/restlessness or feeling keyed up
Tension (muscle tension)
Concentration difficulty (“mind going blank”)
Hyperarousal/irritability
Energy decreased (fatigue)
Restlessness (overlaps, but commonly tested)
Sleep disturbance

(Official DSM-style set is: restlessness, fatigue, difficulty concentrating, irritability, muscle tension, sleep disturbance.)

Common Physical Findings (Often in the stem)

Muscle tension, headaches
GI upset (nausea, diarrhea)
Tremulousness
Sympathetic symptoms (not as “episodic” as panic)

High-Yield Comorbidities

Major depressive disorder
Other anxiety disorders
Substance use (self-medication with alcohol/benzos)

Diagnosis: Criteria + Rule-Outs (Very Testable)

GAD is a clinical diagnosis. Step 1 loves asking you to rule out conditions that can look like anxiety.

Diagnostic Checklist (Practical)

Excessive worry about multiple areas
More days than not for $\ge 6$ months
Difficult to control
$\ge 3$ associated symptoms
Causes clinically significant distress/impairment
Not due to substance/medical condition
Not better explained by another psychiatric disorder

Medical Mimics to Exclude (Classic Step 1)

Mimic	Clues	Workup/Hint
Hyperthyroidism	weight loss, heat intolerance, tremor	Low TSH, high T4
Pheochromocytoma	episodic headaches, sweating, palpitations	metanephrines
Arrhythmia	palpitations, syncope	ECG
Asthma/COPD	dyspnea, wheeze	PFTs
Substance-induced anxiety	caffeine, stimulants, cocaine, withdrawal	history + tox screen
Medication-induced	albuterol, levothyroxine excess, steroids	med list

Differentiating GAD from Related Disorders (Favorite Exam Move)

Disorder	Key Feature	Duration/Pattern
GAD	chronic, diffuse worry + tension	$\ge 6$ months, most days
Panic disorder	recurrent panic attacks + fear of future attacks	attacks are episodic
Social anxiety disorder	fear of negative evaluation	social/performance situations
Specific phobia	fear of a specific object/situation	immediate fear response
PTSD	trauma + intrusion/avoidance + mood/cognition changes + arousal	$\ge 1$ month after trauma
OCD	intrusive thoughts + compulsions	ritualistic behaviors
Illness anxiety	fear of having illness despite reassurance	minimal/no somatic symptoms

Treatment: First-Line, Alternatives, and Mechanisms (Step 1 Essentials)

First-Line (Long-Term Control)

CBT (especially cognitive restructuring + worry exposure/management)
SSRIs (e.g., sertraline, escitalopram)
SNRIs (e.g., venlafaxine, duloxetine)

High-yield pharmacology note: SSRIs/SNRIs take weeks to work. Early transient anxiety can happen—sometimes clinicians use short-term adjuncts.

Second-Line / Adjunct Options

Buspirone (great Step 1 drug)
Hydroxyzine (sometimes used short-term; sedating antihistamine)
Benzodiazepines (short-term, acute relief; avoid long-term dependence)

The “Why” Behind the Drugs (Mechanisms You Can’t Miss)

SSRIs/SNRIs

Increase serotonergic (and for SNRIs, noradrenergic) signaling.
Adverse effects (HY): GI upset, sexual dysfunction, insomnia/sedation, initial anxiety activation; serotonin syndrome risk with combinations.

Buspirone (High Yield)

Mechanism: 5-HT $_{1A}$ partial agonist
Use: GAD (not acute panic relief)
Key features:
- No sedation, no respiratory depression
- No dependence (unlike benzos)
- Takes 1–2+ weeks to work

First Aid cross-reference: often listed under anxiolytics with the key line “5-HT1A partial agonist used for GAD.”

Benzodiazepines

Mechanism: increase frequency of GABA-A channel opening
Pros: rapid symptom relief
Cons: sedation, falls, dependence, withdrawal (can cause seizures), respiratory depression when combined with other CNS depressants

High-Yield Associations & Exam Tips

What the vignette usually looks like

“For the past 8 months she has felt on edge and worries about work performance, finances, and family health… difficulty sleeping… muscle tension… trouble concentrating.”

Common question styles

Pick the diagnosis (GAD vs panic vs thyroid disease)
Pick first-line management (CBT + SSRI/SNRI)
Pick the best add-on if worried about dependence (buspirone)
Mechanism questions (buspirone = 5-HT1A partial agonist, benzos = GABA-A frequency)

Red flags that point away from GAD

Discrete episodes peaking within minutes → think panic attack
Single trigger (e.g., spiders) → specific phobia
Trauma + flashbacks/nightmares → PTSD
Unexpected weight loss + heat intolerance → hyperthyroidism

Rapid Review Table (Last-Minute Step 1)

Category	GAD High-Yield
Duration	$\ge 6$ months
Core	Excessive worry about multiple domains, hard to control
Symptoms	$\ge 3$ : restlessness, fatigue, poor concentration, irritability, muscle tension, sleep disturbance
First-line tx	CBT + SSRI/SNRI
Key alt	Buspirone (5-HT $_{1A}$ partial agonist; delayed onset; no dependence)
Big rule-out	Hyperthyroidism, substance/medication induced anxiety

Quick Practice: One-Liner Recall (Useful on Test Day)

GAD = $\ge 6$ months of excessive, uncontrollable worry + 3+ tension/insomnia/concentration symptoms; treat with CBT + SSRI/SNRI, consider buspirone; avoid chronic benzos.